SciSparc Ltd. (SPRC)
NASDAQ: SPRC · Real-Time Price · USD
0.3080
+0.0022 (0.72%)
At close: Jun 27, 2025, 4:00 PM
0.3099
+0.0019 (0.62%)
After-hours: Jun 27, 2025, 7:57 PM EDT
SciSparc Employees
SciSparc had 2 employees as of December 31, 2024. The number of employees decreased by 1 or -33.33% compared to the previous year.
Employees
2
Change (1Y)
-1
Growth (1Y)
-33.33%
Revenue / Employee
$653,000
Profits / Employee
-$3,142,000
Market Cap
3.46M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
SPRC News
- 3 days ago - SciSparc Announces 1-for-21 Reverse Share Split - GlobeNewsWire
- 4 weeks ago - SciSparc Announces Publication of Japanese Patent Application - GlobeNewsWire
- 2 months ago - SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders - GlobeNewsWire
- 4 months ago - SciSparc Signs Definitive Agreement to Sell MitoCareX, Computational Drug Discovery Company Targeting Resistant Cancers - GlobeNewsWire
- 4 months ago - SciSparc Extends $2 Million Loan to Support AutoMax's Growth Following AutoMax's Entry into Direct Import of JAC Electric Vehicles - GlobeNewsWire
- 4 months ago - SciSparc Secures Favorable Settlement in Lawsuit It Filed, Receiving Cash Compensation and a Full Release from All Commitments, Royalties, and Allegations Asserted Against It on Claimed Core Technology - GlobeNewsWire
- 5 months ago - SciSparc-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour Combination Treatment in Mexico - GlobeNewsWire
- 5 months ago - SciSparc Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement - GlobeNewsWire